ConvaTec Group (LON:CTEC)‘s stock had its “hold” rating restated by research analysts at Peel Hunt in a report released on Friday, March 2nd. They presently have a GBX 210 ($2.90) price objective on the stock. Peel Hunt’s target price would indicate a potential upside of 6.60% from the company’s previous close.
Other analysts also recently issued research reports about the company. Credit Suisse Group reduced their price objective on ConvaTec Group from GBX 225 ($3.11) to GBX 215 ($2.97) and set a “neutral” rating for the company in a research report on Thursday, February 15th. Citigroup reiterated a “neutral” rating and issued a GBX 226 ($3.12) price objective on shares of ConvaTec Group in a research report on Friday, February 16th. Morgan Stanley restated an “overweight” rating and set a GBX 249 ($3.44) target price on shares of ConvaTec Group in a research report on Friday, February 23rd. Numis Securities restated a “hold” rating and set a GBX 180 ($2.49) target price on shares of ConvaTec Group in a research report on Thursday, February 15th. Finally, Deutsche Bank restated a “sell” rating and set a GBX 180 ($2.49) target price on shares of ConvaTec Group in a research report on Friday, December 1st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company’s stock. ConvaTec Group currently has a consensus rating of “Hold” and an average target price of GBX 237.36 ($3.28).
ConvaTec Group (LON CTEC) traded up GBX 1.70 ($0.02) on Friday, reaching GBX 197 ($2.72). The company’s stock had a trading volume of 2,565,592 shares, compared to its average volume of 5,440,000. The firm has a market cap of $3,820.00 and a price-to-earnings ratio of 3,283.33. ConvaTec Group has a 12-month low of GBX 181.40 ($2.51) and a 12-month high of GBX 349.10 ($4.82).
COPYRIGHT VIOLATION WARNING: “Peel Hunt Reaffirms Hold Rating for ConvaTec Group (CTEC)” was originally posted by BBNS and is the sole property of of BBNS. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://baseballnewssource.com/2018/03/27/convatec-groups-ctec-hold-rating-reiterated-at-peel-hunt/1959913.html.
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.